RJFSA
TXG icon

Raymond James Financial Services Advisors’s 10x Genomics TXG Stock Holding History

Raymond James Financial Services Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$651K Buy
+28,844
New +$596K ﹤0.01% 2433
2021
Q2 		– Sell
-1,930
Closed -$349K – 3380
2021
Q1 		$349K Buy
+1,930
New +$333K ﹤0.01% 2529

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Raymond James Financial Services Advisors's TXG Position: Q3 2024 in Review

Raymond James Financial Services Advisors opened a new position in 10x Genomics (TXG) in Q3 2024: 28,844 shares worth $651K. The stake represents ﹤0.01% of the portfolio and ranks #2433 among its holdings. This is a return to the name: Raymond James Financial Services Advisors previously reported a position in TXG as recently as Q1 2021.

Raymond James Financial Services Advisors first reported a position in TXG in Q1 2021 and has held it in 2 quarters since. 266 funds tracked by Wall St. Rank hold TXG as of Q3 2024.

  • Raymond James Financial Services Advisors held 28,844 shares of 10x Genomics worth $651K as of Q3 2024.
  • 10x Genomics was a new Raymond James Financial Services Advisors position in Q3 2024.
  • 10x Genomics made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #2433 holding.
  • Raymond James Financial Services Advisors first reported a position in 10x Genomics in Q1 2021 and has held it in 2 quarters since.
  • 266 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.